According to National Business Daily, citing an announcement by WuXi AppTec, the DNA Encoded Library (DEL) platform under its biology business unit recently experienced a cybersecurity incident [1]. The company activated its incident response, engaged external cybersecurity experts and legal counsel to investigate, and proactively contacted relevant clients [1]. As of the announcement, the company stated that its systems and operations remain normal and no evidence has been found that data was publicly disclosed, misused, or improperly exploited [1].
WuXi AppTec Discloses Cybersecurity Incident Involving DEL Platform
1 min read
- Disclosed
- Aug 25, 2026
- Published
- Nov 10, 2026
- Last updated
- Nov 7, 2026
- CVSS basis
- Our assessment
- Attack vector
- Actor type
- Motivation
On this page
30-second summary
What happened
Who is affected
Industries mainly affected: Healthcare
What to do nowOur advice
As of the announcement, the company stated that its systems and operations remain normal and no evidence has been found that data was publicly disclosed, misused, or improperly exploited [1]
Timeline
- Incident publicly disclosed[1]
Technical details
Source-Supported Details
As of the announcement, the company stated that its systems and operations remain normal and no evidence has been found that data was publicly disclosed, misused, or improperly exploited [1].
Source excerpt: "After market close on August 24, WuXi AppTec (603259.SH, share price RMB 155.84, market cap RMB 465 billion) issued a Voluntary Announcement disclosing that the DNA Encoded Library platform (DEL platform) of its biology business segment recently experienced a cybersecurity incident." [1].
References
Media1
- [1]
“8月24日盘后,药明康德(603259.SH,股价155.84元,市值4650亿元)发布《自愿性公告》,披露其生物学业务板块的DNA Encoded Library平台(DEL平台)近期遭遇一起网络安全事件。”
This site aggregates public information and is not security consulting advice. Test remediation steps before applying.